West Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on West Virginia Healthcare Press.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 4, 2025

November 4, 2025

Enara Bio’s DARKFOX Discovery Propels ENA101, the First Ever Bispecific T Cell Engager Targeting a Cancer-Specific Dark Antigen, into IND-Enabling Studies

GlobeNewswire

November 4, 2025

Abalos Therapeutics to Present Preclinical Data Highlighting Potent, Synergistic Effects of ABX-001 in Combination with Bispecific T-cell Engagers at SITC 2025

GlobeNewswire

November 4, 2025

AIM ImmunoTech Announces Late Breaking Abstract from University of Pittsburgh Medical Center Accepted for Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting

GlobeNewswire

November 4, 2025

Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting

GlobeNewswire

November 4, 2025

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

GlobeNewswire

November 4, 2025

WORK Medical Technology Group LTD’s Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation

GlobeNewswire

November 4, 2025

Marius Pharmaceuticals Leads Effort to Redefine Women’s Health Through Testosterone Research

GlobeNewswire

November 4, 2025

RESET™ Clinical Trial Demonstrates Superior Pain Relief with SPRINT® PNS Compared to Standard Interventional Management for Chronic Low Back Pain

GlobeNewswire

November 4, 2025

Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire

November 4, 2025

Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors

GlobeNewswire

November 4, 2025

Intelerad Expands Strategic Alliance with AWS to Advance Enterprise Imaging in the Cloud

GlobeNewswire

November 4, 2025

Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies

GlobeNewswire

November 4, 2025

BiomX Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections

GlobeNewswire

November 4, 2025

Intumescent Coatings Market worth $1.44 billion by 2030, at a CAGR of 4.1%, says MarketsandMarkets™

GlobeNewswire

November 4, 2025

CVRx to Present at the Jefferies Global Healthcare Conference in London

GlobeNewswire

November 4, 2025

Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025

GlobeNewswire

November 4, 2025

Sofwave Medical Reports Third Quarter 2025 Financial Results and Business Highlights

GlobeNewswire

November 4, 2025

RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th

GlobeNewswire

November 4, 2025

Aligos Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire

November 4, 2025

Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association’s Sessions 2025 in New Orleans

GlobeNewswire